Member Info for JustHereForHemo

Nice to see some love on the board, good show all!

Probably pumpkin, she has went quiet so guessing thats why.

There is a reason why I am careful to only post what I can reference from RNS's or other public sources on here. That does not mean that I dont speak to brokers/directors/other interested parties both in relation to Hemogenyx and other companies I follow. I do. But if you dare to post anything you cannot reference to a RNS or other attributable source people will jump down your throat and demand you either name your source or call you a liar.
That does not mean I have inside information, but it does mean that I am able to satisfy myself and my confidence in my investment. Those who wish to have snide digs should be aware that because of those snide digs those who may very well have much more detailed knowledge than pingu or myself are probably put off from posting here lest they feel the wrath of those who feel slighted. Personal gratification at the expense of a better educated and informed investment, the very definition of cutting off your nose to spite your face.

Some people really need to learn the difference between inside information and a company providing reassurance to shareholders on a topic that many are familiar with and that they have been very open about.
HT, if you just want to keep burning bridges dont be surprised not to get a reply.
Do get a sense that certain posters get more satisfaction in launching attacks and getting in snide digs rather than caring about their own investment.
Thanks Pingu for your post but it appears some want to remain as in the dark as possible so why try and help?
There is a saying about leading a horse to water....
For the record, in terms of CEO and director feedback to investors Hemo is one of the most tightly lipped. Many CEO's in other small caps speak openly to investors who contact them and provide much more detailed updates. Not that its even needed, the last RNS made it perfectly clear that IND was nearing completion.

Micky, I agree with you, which is why i still post. Let's be honest, nothing anyone posts on here is ever going to pursuade me to buy or sell. Just feel we have an obligation to call out bull when we see it, I am eternally grateful to see so many people now posting here who actually have done some research.

Surely someone has been convinced by our new resident expert to sell? He must have atleast one supporter ready to dump on the bell tomorrow? Based on posts on LSE alone he clearly knows more about the IND process than Dr Sandler, CEO of Hemogenyx who is actually doing the IND application, has been speaking with the FDA and was targeting last week for submission. But stu has 192 posts and sounds very confident so I don't know who to believe?????

Good thing they started working on it like 2 years ago then :'-D but great effort, good to see your still out. Nothing worse than trolls getting lucky and buying just before a significant move.

Enjoy your weekend Stu, hopefully your short, personally I doubt it at this point, tone has changed and you have moved into just an argumentative tool mode. Think you misunderstand my point, Vlad picking a date many months ahead to aim for and then missing that by a few days is hardly a big deal, vs something like failing to file company accounts on time which actually matters. Anyway, I am pleased to see since you have changed your tune (Dont get me wrong still annoying :P but clearly you have bought in) I have not seen any significant buying which would match the stature you try and portray for yourself. So I am going to guess you have bought like 1m or less, which is pretty irrelevant. Shame you have put in so much effort for hardly any drop and such a small holding, but again credit where due you have improved your act, much cleaner and more effective.
Have a good weekend, dinner awaits!

Probably worth mentioning that many on this board DO make regular contact with brokers, directors, dentists, hill walkers etc connected to this share.

It happens on EVERY stock on LSE, if there was likely to be a delay then the loyal posters would be prepping the ground, making excuses and downplaying the significance or trying to switch focus to something else.

That is not the case. A handful of days does not justify calling it a delay especially when its a self imposed target.
Personally I am expecting IND imminently and would not be at all surprised if it has already been filed or is coming in the next day or two.

IND is big, it marks the transition from pre to Clinical.
Sit on the side lines and watch whilst you get NT to buy when it lands if you wish, will just help push the SP higher on the day if more people try to buy AFTER the RNS :-)

Worth remembering a few points:
1, This was a self imposed target made by Vlad many months ago as an estimate of when he believed it would be ready, based on what we know he is pretty damn close to hitting it.
2, The target is for IND submission, he could have filed it already or could potentially do so today before the weekend and RNS on Monday and still hit his target.
3, Again, this was a target set by himself for himself, missing it by a few days has zero impact on the IND itself.
4, Its better to double check and get it right than rush and have the FDA bounce it back.
5, Have a good weekend everyone :-)

Certainly looks like Mr 500k is gone which is great news.
For those that are interested, Interactive Brokers showed 100mil available stock on 25th January, the day before the placing. On the day of the placing that dropped to and remains closer to 0. They had around 320m available for a few years up until 27th July last year when it dropped by over 200m overnight. Many will recall the ongoing frustration experienced here last year with what felt like a never ending supply of large sells. Since the placing we had it again, a never ending supply of large sells. Hearing from brokers its not placing shares, and with ~300m total volume since the placing 100m of a dump feels about right, there has been enough churn to allow those to be sold, bought and 100m of additional churn.
Anyway, its more a FYI, showing available stock as 0 and the last big sell we saw was 2m a few days ago so it looks like its gone. Whoever it was has probably got the stock in the previous placing at 1.5p so still made a very good profit, but unless some other big holder comes out of the woodwork and throws a hissy fit HOPEFULLY there wont be anything to hold us back next time we take off.

Agree with both, IND first and its not good for your ISA when a share moves to the USA..
Some history to read if people are bored:
https://hemogenyx.com/wp-content/uploads/2020/02/Aruwon_expert_report_final_20170908.pdf
This is very old, but its interesting to see that under the competition back then magenta therapeutics were listed as main competition for both CDX and Hu-PHEC, back when thats all Hemo had, before HEMO-CAR-T, before CBR. They had raised £50mil and have since raised alot more. Now several years later Vlad has not even raised half of what they started with, has a much bigger pipeline and is still standing whilst the competition is shutting down. They are closing up shop having put a hold on all ongoing trials and yet STILL their mCap is double that of Hemogenyx!
Madness, this SP is unsustainable, a rerate is coming.

Its certainly possible to dual list and it was suggested looked at in the past and very possible in the future.
Personally I dont want them to move to NASDAQ as that would cause issues for me in terms of ISA holding etc however dual listing would be fine.
That said, I would be shocked if they did this now, what with the IND application, CBR trials, the placing "opportunity" and various other things that are ongoing I dont believe Vlad would take on listing in the US right now purely from a point of view of time and costs associated with it. So from me- not right now but absolutely on the radar.

It was the Dentist HT!
How do I know this? I can read..... Its right there in black and white.
This is a stupid discussion, Hemogenyx are not an authorised Quality Unit and cannot self certify that the PQ passed all tests. TheVid posted a link and if you follow that you can find this link:
https://www.fda.gov/media/71021/download
Seriously anyone who is trying to argue that Hemogenyx sat a test and are allowed to mark their own test paper is an idiot.
3 Runs, each tested by a third accredited Quality Unit of which we are certain runs 1 and 2 have passed and run 3 I VERY STRONGLY BELIEVE has passed.
If people want to believe anything different and sell or short, I honestly don't give a monkeys butt crack, I will enjoy watching them trying to buy back when RNS lands :-)

Love the effort Stu, honestly setting aside Hemogenyx, the SP, human to human, you are doing a much better job now. Literate, good use of grammar, no abuse, nothing that people can report you for. Injection of just enough doubt while twisting words and trying to generate conflict and distract the masses from the more positive posts. Use of line breaks to push positive posts down the page. Posting in line with sells to encourage more selling.
So honestly, credit where credit is due.
That said, your talking bs, FDA require 3 tested runs. They are not going to trust Hemogenyx to self certify. A third party has tested all 3.

3 Weeks ago Hemogenyx was sitting at 4p in anticipation of IND having completed and verified 2 out of 3 runs with 3rd party sign off.
Since then Run 3 has been sent away and will have been returned by now, no RNS required to confirm its been tested but absolutely an RNS WOULD be required if it had failed. This was the final stage in IND submission, which I assume will come in the coming hours or days.
On the 26th January we had a placing to take advantage of an opportunity, this being after the FDA halted trials by Magenta Therapeutics following the death of a patient. They then announced that they were moving to wind down their company, which means fire sale, delist and distribute cash to shareholders. Vlad had previously stated that Hemogenyx were funded to take CAR-T into clinical trials so the timing of the Placing came as a surprise to many.
MGTA-145 looks strikingly close to Hu-PHEC but already in clinical trials and past the point of IND etc.
Vlad tweeted but quickly deleted a link to Magenta, obviously nothing is a given but I believe there is a chance the placing money was to take advantage of a firesale at Magenta, it gives Hemo a boost into clinical status and MGTA-145 compliments CDX and CAR-T giving full end to end treatment.
Its possible I am wrong, but SOMEBODY has to take MGTA-145 and whoever it is would become a competitor to Hemogenyx, better to swallow up the competition and leapfrog into clinical status.
On the same day we had an immediate tank of SP BELOW Placing price, we have had confirmation from multiple sources that the share were being sold by an existing shareholder, clearly someone who saw the placing as signs of a delay. But where is the evidence of a delay? No RNS to say run 3 failed which would be necessary and all the whispers I have heard are positive.

So from where I sit, I have ZERO reason to believe IND will be delayed and could land at any point any day going forward.
I have every belief that the placing was not just to pad the bank and Vlad had a reason, maybe his tweet was a red herring but maybe not. If I am right then some sort of update should clarify which can only be good for us and help dispel the myth of delays or needing cash.
CBR in vivo tests started over a month ago so results there are due any time now, I think in the CDX trials all mice were put down after 21 days? So we are in the ball park when CBR news for Covid-19 is due
CBR update related to the other testing or partners - No clue, cannot judge.

There is literally NOTHING in the public domain, be it in RNS, via tweet or even via rumors that there is anything negative hanging over Hemogenyx. The attempts to inject doubt with irrelevant semantics is just childish and pathetic IMO.

Wonder what it does to the SP if I am right and 1, 2 or 3 of the above updates land in quick succession....

Pumpkin, if all 3 are identical why would you NOT get the 1st one verified?
These are coming from a single human doner, who knows, maybe they had some rare blood disorder and the CAR-T could have been useless. Why waste 3 months doing 3 runs just to find the first one failed but they never bothered to test.....
Its irrelevant, I am 99.99% sure they tested all 3 with third party as they went as is required by the FDA and your fluffing of Stu is just comical, but I am sure he is getting a semi none the less :P

Funny that, we keep claiming that the runs are completed, almost like we just blindly read the RNS :P The title of which was:
"HEMO-CAR-T Process Qualification Run Completed"
:-D

Stu, stand by your convictions, no point wasting your time here if your not going to back yourself, I am sure there are shares out there to borrow somewhere, go short and put your money where your mouth is :-)

Push. You actually think that vlad would have proceeded to run 2 and 3 without first having the first run checked by the third party?
The difference was he waited for results from run 1 and 2 before rns, run 3 was RNS'ed before results came back.